SALT LAKE CITY, UT--(Marketwire - April 29, 2010) -
Paradigm Medical Industries, Inc. (PINKSHEETS: PDMI
) announced today that Stephen L. Davis, the Company's President and CEO, will be attending ARVO, an ophthalmic research and product development meeting to be held in Ft. Lauderdale, Florida from May 1-5, 2010. Paradigm will utilize this meeting to introduce its new Paramax, which remains under FDA review, and its FDA approved Blood Flow Analyzer™ as new and innovative diagnostic devices for early detection of glaucoma. Mr. Davis will also meet with representatives from other ophthalmic research organizations to discuss opportunities for Paradigm to participate in new product development partnerships.
About Paradigm Medical Industries, Inc.
Headquartered in Salt Lake City, Utah, Paradigm Medical Industries, Inc. is a medical device company that develops, manufactures and distributes ophthalmic diagnostic instruments and related products for early detection of glaucoma and other eye disorders. The Company's primary objective is to capture a niche market within the glaucoma and ultrasound microscopy fields. Paradigm Medical Industries markets its products to ophthalmologists, optometrists, universities, and clinics throughout the United States and internationally.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
For more information, please visit: www.paradigm-medical.com